Recombinant Human MBD4

Product Specifications

Product Name Alternative

3 N (4) ethenocytosine glycosylase, G/5 fluorouracil mismatch glycosylase with biphasic kinetics, G/T mismatch glycosylase, G/U mismatch glycosylase, MBD 4, MBD4, MBD4_HUMAN, MED 1, MED1, Methyl CpG binding domain protein 4, Methyl CpG binding endonuclease 1, Methyl CpG binding protein MBD4

UniProt

O95243

Expression Region

68-300

Host

E.Coli

Tag

N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process

Applications

Western Blot, ELISA

Field of Research

Metabolism, Developmental biology

Purity

Greater than 90% as determined by SDS-PAGE.

Form

Lyophilized powder

Reconstitution

Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.

Molecular Weight

25.5 kDa

Shipping Conditions

4°C with ice bag

Storage Conditions

The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.